# Abbott acquires Cephea Valve Technologies, developer of a minimally invasive mitral valve replacement device

Abbott exercised its option to acquire Cephea Valve Technologies, a private medical device company developing a minimally invasive heart valve replacement for mitral valve disease. Financial terms were not disclosed; the announcement is dated 16 January 2019.

- Type: Acquisition
- Announced: 2019-01-16
- Status: completed
- Products: mitral valve replacement system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Abbott](https://endata.com/companies/4479.md) (acquirer)
- [Cephea Valve Technologies](https://endata.com/companies/4480.md) (target)

## Sources

- [tecnomedicina.it](https://www.tecnomedicina.it/abbott-acquisisce-cephea-valve-technologies/), 2019-01-16: "Abbott ha annunciato di aver esercitato la sua opzione per l’acquisto di Cephea Valve Technologies, un’azienda privata di dispositivi medici."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.